Neuropsychiatric systemic lupus erythematosus

Last updated
Neuropsychiatric systemic lupus erythematosus
Other namesCNS lupus, lupus cerebritis
Specialty Rheumatology, neurology, psychiatry

Neuropsychiatric systemic lupus erythematosus (NPSLE) refers to the neurological and psychiatric manifestations of systemic lupus erythematosus (SLE). SLE is an autoimmune disease that can affect many of the body's organs and systems. It is estimated that over half of people with SLE have neuropsychiatric involvement. [1]

Contents

Classification

The American College of Rheumatology (ACR) has outlined 19 syndromes that are seen in NPSLE. These syndromes encompass disorders of the central and peripheral nervous systems: [2]

Each of the 19 syndromes are also stand-alone diagnoses that can occur with or without primary SLE.

The majority of cases involve the central nervous system (CNS), which consists of the brain and spinal cord. [2] The most common CNS syndromes are headache and mood disorder. [1]

Though neuropsychiatric lupus is sometimes referred to as "CNS lupus", it can also affect the peripheral nervous system (PNS). Between 10–15% of people with NPSLE have PNS involvement. [3] Mononeuropathy and polyneuropathy are the most common PNS syndromes. [1]

Other syndromes

Some neurological syndromes outside of the ACR classification may also be considered NPSLE manifestations. These include neuromyelitis optica, posterior reversible encephalopathy syndrome, small fiber neuropathy, [4] and Lambert–Eaton myasthenic syndrome. [5]

Pathogenesis

There are several possible mechanisms that underlie the nervous system manifestations of lupus. Specific syndromes may be vasculopathic, autoantibody-mediated, or inflammatory in nature.

There is evidence that the blood–brain barrier, which protects the CNS, is compromised in patients with NPSLE. As a result, autoantibodies are able to infiltrate the CNS and cause damage. [6]

Diagnosis

For the diagnosis of NPSLE, it is crucial to ascertain whether neuropsychiatric symptoms are indeed a consequence of SLE itself, whether they constitute a distinct comorbid condition, or whether they are a side effect of disease SLE treatment. Furthermore, the onset of neuropsychiatric symptoms may precede the diagnosis of SLE. [7] Due to the lack of uniform diagnostic standards, statistics about NPSLE vary widely. [8] Diagnostic testing modalities that may aid in diagnosis include MRI, electrophysiological studies, psychiatric evaluation, and autoantibody tests. [9]

Treatment

Management of NPSLE is similar to the management of neuropsychiatric illness in patients without lupus. Treatment depends on the underlying causes of a patient’s symptoms, and may include immunosuppressants, anticoagulants, and symptomatic therapy. [9]

See also

References

  1. 1 2 3 Unterman, Avraham; Nolte, Johannes ES; Boaz, Mona; Abady, Maya; Shoenfeld, Yehuda; Zandman-Goddard, Gisele (August 2011). "Neuropsychiatric Syndromes in Systemic Lupus Erythematosus: A Meta-Analysis". Seminars in Arthritis and Rheumatism. 41 (1): 1–11. doi:10.1016/j.semarthrit.2010.08.001. ISSN   0049-0172. PMID   20965549.
  2. 1 2 Liang, Matthew H; Corzillius, Michael; Bae, Sang Cheol; Lew, Robert A; Fortin, Paul R; et al. (April 1999). "The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes". Arthritis and Rheumatism. 42 (4): 599–608. doi: 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F . ISSN   0004-3591. PMID   10211873.
  3. Kivity, Shaye; Agmon-Levin, Nancy; Zandman-Goddard, Gisele; Chapman, Joab; Shoenfeld, Yehuda (March 2015). "Neuropsychiatric lupus: a mosaic of clinical presentations". BMC Medicine. 13 (1): 43. doi: 10.1186/s12916-015-0269-8 . ISSN   1741-7015. PMC   4349748 . PMID   25858312.
  4. Bortoluzzi, Alessandra; Scirè, Carlo Alberto; Govoni, Marcello (14 March 2018). "Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus". Frontiers in Medicine . 5: 68. doi: 10.3389/fmed.2018.00068 . PMC   5861139 . PMID   29594125.
  5. West, Sterling G; Hanly, John G (2019). "Lupus and the Nervous System: Clinical Aspects, Psychopathology, and Imaging". In Wallace, Daniel J; Hahn, Bevra Hannahs (eds.). Dubois' Lupus Erythematosus and Related Syndromes (Ninth ed.). Elsevier. pp. 434–456. doi:10.1016/B978-0-323-47927-1.00036-0. ISBN   978-0-323-47927-1. S2CID   80722393.
  6. Stock, Ariel D; Wen, Jing; Putterman, Chaim (December 2013). "Neuropsychiatric lupus, the blood brain barrier, and the TWEAK/Fn14 pathway". Frontiers in Immunology. 4: 484. doi: 10.3389/fimmu.2013.00484 . ISSN   1664-3224. PMC   3872310 . PMID   24400009.
  7. Bertsias, GK; Ioannidis, JPA; Aringer, M; Bollen, E; Bombardieri, S; et al. (2010). "EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs". Annals of the Rheumatic Diseases. 69 (12): 2074–2082. doi: 10.1136/ard.2010.130476 . ISSN   0003-4967. PMID   20724309.
  8. Gulinello, Maria; Wen, Jing; Putterman, Chaim (September 2012). "Neuropsychiatric Symptoms in Lupus". Psychiatric Annals. 42 (9): 322–328. doi:10.3928/00485713-20120906-05. PMC   4302271 . PMID   25620816.
  9. 1 2 Magro-Checa, Cesar; Zirkzee, Elisabeth J; Huizinga, Tom W; Steup-Beekman, Gerda M (2016). "Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives". Drugs. 76 (4): 459–483. doi:10.1007/s40265-015-0534-3. ISSN   0012-6667. PMC   4791452 . PMID   26809245.